Search

Author/Creator Brown, Michelle

4. 1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections. (26th November 2018)

Authors:
Kaye, Keith; File, Thomas; Boucher, Helen W; Brown, Michelle; Aggrey, Angela; Khan, Ireen; Joeng, Hee-Koung; Tipping, Robert; Du, Jiejun; Young, Katherine; Butterton, Joan; Kartsonis, Nicholas A; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections. (26th November 2018)

Authors:
Brown, Michelle; Motsch, Johann; Kaye, Keith; File, Thomas; Boucher, Helen W; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert; Du, Jiejun; Depestel, Daryl D; Butterton, Joan; Kartsonis, Nicholas A; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗